JPMorgan pushes back expectations for first Fed rate cut to November
Due to stronger-than-expected U.S. employment data in May, JPMorgan Chase economists will be the Federal Reserve's first interest rate cut forecast from July to November. Previously, JPMorgan Chase is one of the few institutions that still predicts that the Fed will cut interest rates in July. The bank's chief U.S. economist Michael Feroli now expects the Fed will cut interest rates for the first time in November, and next year will also be consecutive quarterly rate cuts. In May after the release of non-farm payrolls data, Feroli said, “the possibility of a rate cut in July now seems minimal. From now to September three employment reports, household survey indicators are expected to be weaker, but given the recent momentum of job growth, we think it may take from now to November five reports show weakness to pass the rate cut test.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment
According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.
After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.
Crypto prices
More
